Retatrutide 40mg

Triple GIP, GLP-1, and Glucagon Receptor Agonist

Uncompromising Precision for Advanced Metabolic Assays

High-purity Retatrutide, a highly specialized, synthetic peptide engineered to act as a triple agonist for the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors.

In an in-vitro environment, this complex compound allows researchers to study the synergistic effects of simultaneous triple-receptor activation. It is a critical component for prolonged cellular culture studies focusing on advanced metabolic regulation, lipid metabolism, and the modulation of cellular energy expenditure. Available in a highly concentrated 40mg format, this lyophilized compound ensures exact yields and sustained stability for your most demanding, high-volume laboratory assays.

🔬 Key Research Applications:

• Advanced Metabolic Pathway Analysis: Essential for in-vitro assays measuring the complex signaling pathways of GIP, GLP-1, and glucagon receptors across isolated cellular models.

• Energy Expenditure & Lipolysis Models: An ideal compound for empirical research observing lipid metabolism mechanics, cellular energy expenditure, and the unique dynamics of a tri-agonist.

• Receptor Binding Assays: Frequently utilized in tissue cultures to study competitive binding, receptor downregulation, and the structural dynamics of triple agonism.

Technical Specifications:

• Net Content: 40mg

• Format: Lyophilized Powder

• Storage Requirements: 2°C – 8°C (Refrigeration required to maintain structural integrity)

⚠️ Legal Disclaimer: All products supplied by Perth Peptides are strictly for in-vitro, laboratory, and scientific research purposes only. They are not intended for human consumption, veterinary use, diagnostic, or therapeutic applications. By purchasing, the researcher assumes full responsibility for safe handling and compliance with all established laboratory protocols.